SNSE

Sensei Biotherapeutics, Inc. Common Stock

$21.14 +20.18%

Recent alerts on SNSE

All signals →

Insider trade Sale by Cambrian BioPharma Inc

Insider trade Sale by Peyer James

Short interest Short interest 60.8% of float

SEC filing SNSE Acquires Faeth Therapeutics, Raises $200M in PIPE Financing, Issues 24.9M Shares of Common Stock on Conversion of Series B Preferred Stock

Insider trade Sale by MILLENNIUM GROUP MANAGEMENT LLC

Insider trade Sale by ICS OPPORTUNITIES II LLC

Insider trade Sale by MILLENNIUM MANAGEMENT LLC

Insider trade Sale by ENGLANDER ISRAEL A

Insider trade Sale by MILLENNIUM GROUP MANAGEMENT LLC

Insider trade Sale by ICS OPPORTUNITIES II LLC

Insider trade Sale by ENGLANDER ISRAEL A

Insider trade Sale by MILLENNIUM GROUP MANAGEMENT LLC

Insider trade Sale by ICS OPPORTUNITIES II LLC

Insider trade Sale by MILLENNIUM MANAGEMENT LLC

Insider trade Purchase by MILLENNIUM MANAGEMENT LLC

Insider trade Sale by ENGLANDER ISRAEL A

Insider trade Sale by MILLENNIUM GROUP MANAGEMENT LLC

Insider trade Sale by ICS OPPORTUNITIES II LLC

Insider trade Sale by MILLENNIUM MANAGEMENT LLC

Insider trade Purchase by ENGLANDER ISRAEL A

Insider trade Purchase by MILLENNIUM GROUP MANAGEMENT LLC

Insider trade Purchase by ICS OPPORTUNITIES II LLC

Insider trade Purchase by MILLENNIUM MANAGEMENT LLC

Insider trade Sale by ENGLANDER ISRAEL A

Insider trade Sale by MILLENNIUM GROUP MANAGEMENT LLC

Get push alerts for SNSE

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS